Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hypereosinophilic Syndrome | 1 | 2021 | 33 | 0.89 | Why? |
| Methotrexate | 2 | 2020 | 471 | 0.77 | Why? |
| Gout | 1 | 2020 | 85 | 0.76 | Why? |
| Granulomatous Disease, Chronic | 4 | 2019 | 60 | 0.73 | Why? |
| Angiotensin I | 1 | 2020 | 200 | 0.71 | Why? |
| Janus Kinases | 1 | 2020 | 414 | 0.64 | Why? |
| Azetidines | 1 | 2020 | 722 | 0.53 | Why? |
| Lymphocyte Subsets | 1 | 2021 | 987 | 0.52 | Why? |
| Colchicine | 1 | 2020 | 730 | 0.51 | Why? |
| Sulfonamides | 1 | 2020 | 1294 | 0.44 | Why? |
| Peptide Fragments | 1 | 2020 | 2075 | 0.39 | Why? |
| Biological Products | 1 | 2020 | 2331 | 0.29 | Why? |
| Myocarditis | 1 | 2021 | 2731 | 0.29 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.24 | Why? |
| NADPH Oxidases | 2 | 2019 | 80 | 0.24 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.23 | Why? |
| Oncogene Proteins, Fusion | 1 | 2021 | 52 | 0.22 | Why? |
| Mycoses | 2 | 2019 | 589 | 0.22 | Why? |
| Mycobacterium Infections | 2 | 2018 | 72 | 0.22 | Why? |
| In Situ Hybridization, Fluorescence | 1 | 2021 | 207 | 0.21 | Why? |
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 229 | 0.20 | Why? |
| STAT Transcription Factors | 1 | 2020 | 173 | 0.19 | Why? |
| Interleukin-12 Receptor beta 1 Subunit | 1 | 2018 | 5 | 0.19 | Why? |
| Receptor, Angiotensin, Type 1 | 1 | 2020 | 160 | 0.19 | Why? |
| Alu Elements | 1 | 2018 | 22 | 0.19 | Why? |
| Cytokines | 2 | 2020 | 15010 | 0.19 | Why? |
| Genetic Diseases, X-Linked | 1 | 2021 | 237 | 0.18 | Why? |
| Receptors, Interleukin-12 | 1 | 2017 | 14 | 0.18 | Why? |
| DNA Copy Number Variations | 1 | 2018 | 84 | 0.18 | Why? |
| Loss of Function Mutation | 1 | 2020 | 244 | 0.18 | Why? |
| Paecilomyces | 1 | 2017 | 9 | 0.18 | Why? |
| Toll-Like Receptor 7 | 1 | 2021 | 402 | 0.17 | Why? |
| Plasmapheresis | 1 | 2020 | 437 | 0.16 | Why? |
| Immune System Diseases | 1 | 2021 | 410 | 0.16 | Why? |
| Aspergillus | 1 | 2018 | 347 | 0.15 | Why? |
| Genetic Association Studies | 1 | 2018 | 559 | 0.14 | Why? |
| Cell Survival | 1 | 2020 | 1581 | 0.14 | Why? |
| Purines | 1 | 2020 | 816 | 0.14 | Why? |
| Pedigree | 3 | 2021 | 502 | 0.13 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2021 | 2483 | 0.13 | Why? |
| Administration, Oral | 1 | 2020 | 2340 | 0.12 | Why? |
| Cell Proliferation | 1 | 2020 | 1973 | 0.12 | Why? |
| Lymph Nodes | 1 | 2019 | 1060 | 0.12 | Why? |
| Molecular Targeted Therapy | 1 | 2020 | 1579 | 0.11 | Why? |
| Alleles | 3 | 2021 | 1557 | 0.10 | Why? |
| Mutation | 3 | 2019 | 12376 | 0.10 | Why? |
| Genetic Predisposition to Disease | 3 | 2020 | 4027 | 0.10 | Why? |
| Pyrazoles | 1 | 2020 | 1791 | 0.10 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.09 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.09 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.09 | Why? |
| Respiratory Tract Infections | 2 | 2019 | 6817 | 0.09 | Why? |
| Gene Expression Regulation | 1 | 2020 | 4020 | 0.08 | Why? |
| Interferon Type I | 1 | 2020 | 2789 | 0.08 | Why? |
| Iran | 4 | 2021 | 5467 | 0.08 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.08 | Why? |
| Skin | 1 | 2019 | 2096 | 0.08 | Why? |
| DNA Mutational Analysis | 2 | 2019 | 581 | 0.08 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.08 | Why? |
| Bacterial Infections | 1 | 2019 | 2229 | 0.07 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.07 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.06 | Why? |
| Humans | 17 | 2021 | 930598 | 0.06 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.06 | Why? |
| Penetrance | 1 | 2021 | 121 | 0.06 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.05 | Why? |
| Interferon Regulatory Factor-7 | 1 | 2020 | 234 | 0.05 | Why? |
| Base Sequence | 2 | 2018 | 3581 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.05 | Why? |
| Tetradecanoylphorbol Acetate | 1 | 2018 | 23 | 0.05 | Why? |
| Rhodamines | 1 | 2018 | 19 | 0.05 | Why? |
| Adult | 7 | 2021 | 244371 | 0.05 | Why? |
| Liver Abscess | 1 | 2019 | 42 | 0.05 | Why? |
| Male | 10 | 2021 | 367725 | 0.05 | Why? |
| DNA, Fungal | 1 | 2018 | 95 | 0.05 | Why? |
| Genetic Loci | 1 | 2020 | 439 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Mycobacterium tuberculosis | 2 | 2017 | 1164 | 0.04 | Why? |
| Receptor, Interferon alpha-beta | 1 | 2020 | 610 | 0.04 | Why? |
| Chromosome Mapping | 1 | 2018 | 178 | 0.04 | Why? |
| Toll-Like Receptor 3 | 1 | 2020 | 391 | 0.04 | Why? |
| Coinfection | 1 | 2017 | 6820 | 0.04 | Why? |
| T-Lymphocytes, Helper-Inducer | 1 | 2020 | 497 | 0.04 | Why? |
| Mycobacterium | 1 | 2017 | 143 | 0.04 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.04 | Why? |
| Child, Preschool | 4 | 2021 | 36283 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.04 | Why? |
| AIDS-Related Opportunistic Infections | 1 | 2017 | 260 | 0.04 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.03 | Why? |
| Child | 5 | 2021 | 70012 | 0.03 | Why? |
| Infant | 3 | 2021 | 30274 | 0.03 | Why? |
| Female | 8 | 2021 | 380317 | 0.03 | Why? |
| Interleukin-6 | 2 | 2021 | 7522 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.03 | Why? |
| Aged | 4 | 2021 | 215776 | 0.03 | Why? |
| HIV Infections | 1 | 2017 | 11620 | 0.03 | Why? |
| Autoimmunity | 1 | 2019 | 841 | 0.03 | Why? |
| Tuberculosis | 2 | 2017 | 2895 | 0.03 | Why? |
| Antitubercular Agents | 1 | 2017 | 775 | 0.03 | Why? |
| Middle Aged | 4 | 2021 | 270681 | 0.03 | Why? |
| Early Diagnosis | 1 | 2019 | 2443 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 2309 | 0.02 | Why? |
| Pilot Projects | 1 | 2021 | 5182 | 0.02 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.02 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.02 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.02 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Lung Diseases | 1 | 2019 | 2361 | 0.02 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2019 | 6740 | 0.02 | Why? |
| Skin Diseases | 1 | 2019 | 2509 | 0.01 | Why? |
| Neutrophils | 1 | 2018 | 5476 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Adrenal Cortex Hormones | 1 | 2018 | 6537 | 0.01 | Why? |
| Lung | 2 | 2018 | 31049 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.01 | Why? |
| Risk Factors | 1 | 2017 | 71621 | 0.01 | Why? |
Mansouri's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(122)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(253)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_